These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 15630036)

  • 1. Restenosis: another "dysfunction" of the endothelium.
    Lerman A
    Circulation; 2005 Jan; 111(1):8-10. PubMed ID: 15630036
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation.
    Patti G; Pasceri V; Melfi R; Goffredo C; Chello M; D'Ambrosio A; Montesanti R; Di Sciascio G
    Circulation; 2005 Jan; 111(1):70-5. PubMed ID: 15630038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis.
    Kitta Y; Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Ichigi Y; Mende A; Kugiyama K
    J Am Coll Cardiol; 2005 Aug; 46(4):648-55. PubMed ID: 16098430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelial dysfunction in cardiovascular diseases: therapeutic implications after coronary angioplasty].
    Bauters C; Meurice T; Van Belle E; Lablanche JM; Bertrand ME
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():35-9. PubMed ID: 9515112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
    Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
    Soares PR; Hueb WA; Lemos PA; Lopes N; Martinez EE; Cesar LA; Oliveira SA; Ramires JA
    Circulation; 2006 Jul; 114(1 Suppl):I420-4. PubMed ID: 16820611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitor in a human model of restenosis. MERCATOR ("Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis") Study Group.
    Heyndrickx GR
    Basic Res Cardiol; 1993; 88 Suppl 1():169-82. PubMed ID: 8357332
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of restenosis after coronary stenting, problem soon resolved].
    Kivelä A; Hartikainen J
    Duodecim; 2005; 121(11):1227-36. PubMed ID: 15999982
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent fracture-unusual cause of DES restenosis.
    Goyal BK
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):993-4. PubMed ID: 17525958
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inflammatory response after coronary angioplasty - mechanisms and significance].
    Koziński M; Kubica J
    Kardiol Pol; 2006 Jul; 64(7):771-4; author reply 775. PubMed ID: 16886140
    [No Abstract]   [Full Text] [Related]  

  • 14. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Anti-healing" versus "pro-healing".
    Seth DA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus.
    Ben-Gal Y; Mohr R; Uretzky G; Medalion B; Hendler A; Hansson N; Herz I; Moshkovitz Y
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):861-6. PubMed ID: 17000298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
    Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
    Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary physiology and its usefulness for the interventionist cardiologist: invasive measurement of coronary flow-pressure].
    Barrera-Ramírez CF; Escaned J
    Arch Cardiol Mex; 2005; 75(3):335-49. PubMed ID: 16294824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty.
    Buszman P; Zurakowski A; Kinasz L; Gorycki B; Król M; Lewicki A; Flak Z; Milewski K; Zurek P
    Kardiol Pol; 2005 May; 62(5):451-9; discussion 460-1. PubMed ID: 15928722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to Meyer.
    Munk PS
    Am Heart J; 2010 Apr; 159(4):e23. PubMed ID: 20362705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.